Pharmafile Logo
Pharmafocus logo
Advanced Search

AZ

Showing 15 posts of 79 posts found.

Astrazeneca image

AstraZeneca’s Fluenz chosen for wider flu immunisation

July 26, 2012
Sales and Marketing AZ, AstraZeneca, Cervarix, Gardasil, Lansley, MedImmune

The UK has chosen AstraZeneca’s Fluenz to extend the country’s flu vaccination programme. The health secretary Andrew Lansley said that …

News

Roche cuts 1,000 R&D jobs

June 27, 2012
Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …

News

AstraZeneca wins fresh US victory with Seroquel XR

April 2, 2012
Sales and Marketing AZ, AstraZeneca, FDA, Seroquel XR

AstraZeneca is celebrating a US court verdict in its ongoing battle for intellectual property over the extended release version of …

News
Quetiapine image

Teva launches generic Seroquel in UK

March 27, 2012
Sales and Marketing AZ, NHS, Quetiapine, Seroquel, Teva

Teva has launched a generic version of the antipsychotic Seroquel on the same day AstraZeneca loses patent protection on its …

News
AstraZeneca picture

AstraZeneca to cut 7,300 jobs as growth stalls

February 2, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AZ, AstraZeneca, David Brennan, R&D

AstraZeneca will make 7,300 cuts to its sales and R&D staff by 2014, but the company has not yet said …

News

Pharma unprepared for annus horribilis

January 12, 2012
Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma

A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …

News
GP prescribing

GPs asked to squeeze drugs bill

April 14, 2011
Sales and Marketing AZ, GPs, NHS, NICE, prescribing

GPs are being asked not to prescribe NICE-approved drugs in order to cut costs.In the last year more than half …

News
AstraZeneca

AZ partners with Galderma on psoriasis research

March 9, 2011
Research and Development AZ, AstraZeneca, Galderma, dermatology, psoriasis

AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …

News

AZ stops making Pulmicort pMDI inhaler

March 8, 2011
Manufacturing and Production AZ, AstraZeneca, Pulmicort, Pulmicort pMDI, Skyepharma, asthma, asthma inhaler, budesonide

AstraZeneca has discontinued production of its Pulmicort pMDI asthma inhaler because of manufacturing issues, and looks set to exit from …

News

Onglyza expands European licence

March 4, 2011
Sales and Marketing AZ, AstraZeneca, BMS, Bristol-Myers Squibb, Onglyza, diabetes, renal impairment, saxagliptin, type II diabetes

European regulators have approved a licence extension for diabetes treatment Onglyza, making it the first drug in its class that …

News

AZ opens new global HQ in London

February 28, 2011
Medical Communications, Sales and Marketing AZ, AstraZeneca, London

AstraZeneca has moved its London global headquarters from Mayfair to new, larger premises in Paddington. The new offices are located …

News

AZ accepts $92.5m to settle respiratory dispute

February 18, 2011
Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory

AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …

News
AstraZeneca's social media white paper

Digital Pharma: AZ presses the case for social media in pharma

February 11, 2011
Medical Communications AZ, AstraZeneca, Digital Pharma blog, FDA, social media

Seemingly fed up with waiting for the FDA’s delayed social media guidance, AstraZeneca has published details of its own feedback …

News

AZ-Targacept depression candidate moves into phase IIb

February 9, 2011
Research and Development AZ, AstraZeneca, TC-5214, Targacept, depression, major depressive disorder

AstraZeneca and Targacept have begun a phase IIb trial of TC-5214 as a ‘switch’ monotherapy for patients with depression. The …

News
AstraZeneca's Iressa (gefitinib)

AZ and Pfizer support personalised medicine database

February 8, 2011
Research and Development AZ, AstraZeneca, Cancer Research UK, Iressa, Pfizer, crizotinib, gefitinib, personalised medicine

AstraZeneca and Pfizer have teamed up with leading charity Cancer Research UK to help develop its stratified medicines programme. Stratified …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026